P/E at 63.39 vs Industry's 61.98: What the Data Shows for Apollo Hospitals Enterprise Ltd.

Valuation Picture: Premium Reflects Confidence but Warrants Scrutiny

The current P/E of 63.39 for Apollo Hospitals Enterprise Ltd. stands just above the hospital sector’s average of 61.98, indicating a valuation premium of approximately 2.3%. This premium suggests that the market is willing to pay slightly more for the company’s earnings relative to its peers, potentially reflecting expectations of superior growth or operational resilience. However, the narrow margin between the stock’s P/E and the industry average invites a closer look at whether this premium is justified by recent performance metrics or if it signals a stretched valuation in a sector where multiples are already elevated.

Given the hospital sector’s typical sensitivity to regulatory changes and healthcare demand cycles, the premium could be interpreted as a cautious endorsement rather than exuberance. Apollo Hospitals Enterprise Ltd.’s market capitalisation of ₹1,16,644.58 crores places it firmly in the large-cap category, which often commands higher multiples due to perceived stability and market leadership.

Performance Across Timeframes: Strong Long-Term Gains with Consistent Momentum

Examining returns across various periods reveals a consistent outperformance relative to the Sensex. Over one year, the stock has gained 17.22%, contrasting with the Sensex’s 7.81% loss. This positive divergence extends to the year-to-date figure, where Apollo Hospitals Enterprise Ltd. has risen 15.19% while the Sensex declined 12.01%. Even over three months, the stock posted a 7.62% gain compared to the Sensex’s 9.25% fall, signalling resilience amid broader market weakness.

Shorter-term momentum is also notable, with a 1-month return of 7.95% and a 1-week gain of 3.50%, both outperforming the Sensex’s negative returns in those periods. The stock’s 1-day performance on 14 June 2026 was a 1.39% increase, slightly underperforming the sector by 0.28%, but still ahead of the Sensex’s 0.50% rise. This suggests that while the stock is generally in favour, it may face intermittent profit-taking or sector-specific headwinds.

The long-term performance is particularly impressive, with 3-year returns of 76.06%, 5-year returns of 158.39%, and a remarkable 10-year gain of 512.72%, all significantly outpacing the Sensex’s respective returns of 20.88%, 53.86%, and 194.16%. This track record underscores the company’s sustained growth and market leadership over the past decade.

Moving Average Configuration: Bullish Across All Key Periods

The technical setup for Apollo Hospitals Enterprise Ltd. is notably strong, with the stock trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. This alignment indicates a sustained upward trend across short, medium, and long-term horizons, signalling broad-based buying interest and technical strength.

Such a configuration is often interpreted as a bullish indicator, suggesting that the stock has recovered from any recent dips and is maintaining momentum. The fact that the stock is just 1.68% away from its 52-week high of ₹8,143.25 further supports the view of a resilient uptrend. However, the stock’s slight underperformance relative to the sector on the day (down 0.28%) and the recent three-day gain following a losing streak highlight the potential for short-term volatility within this broader positive trend — is this a genuine recovery or a relief rally that will fade at the 50 DMA? — the moving average configuration provides the clearest answer.

Sector Performance Context: Hospital Sector Shows Mixed Results

The hospital sector, within which Apollo Hospitals Enterprise Ltd. operates, has exhibited a mixed performance profile recently. While some companies have posted positive gains, others have remained flat or declined, reflecting the sector’s sensitivity to regulatory developments, cost pressures, and demand fluctuations.

Within this environment, Apollo Hospitals Enterprise Ltd.’s ability to outperform the sector and the broader market across multiple timeframes is noteworthy. The stock’s large-cap status and market leadership likely contribute to its relative stability and investor confidence, even as the sector navigates challenges.

Rating Reassessment: Previously Rated Hold, Now Updated

On 11 May 2026, the rating for Apollo Hospitals Enterprise Ltd. was updated from its previous Hold status. While the current rating is not disclosed, the reassessment reflects a fresh evaluation of the company’s fundamentals, valuation, and technicals. The previous Mojo Score stood at 75.0, indicating a solid performance baseline.

This rating change invites investors to consider the implications of the updated analysis — previously rated Hold, what is Apollo Hospitals Enterprise Ltd.’s current rating? The four-parameter analysis factors in the valuation premium, performance trends, and technical configuration to provide a comprehensive view.

Conclusion: Data Reflects a Balanced Yet Positive Outlook

The data for Apollo Hospitals Enterprise Ltd. reveals a stock trading at a slight premium to its sector, supported by strong long-term returns and a bullish technical setup. The consistent outperformance relative to the Sensex across multiple timeframes, combined with the stock’s position above all key moving averages, suggests sustained investor confidence and operational strength.

However, the modest valuation premium and recent short-term volatility highlight the need for careful monitoring. The rating update from Hold to its current status underscores a reassessment of these factors, inviting investors to weigh the balance between valuation and performance — should investors in Apollo Hospitals Enterprise Ltd. hold, buy more, or reconsider?

Limited Period Only. Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Get 72% Off →